PharmacyCodes



(-)-Carnitine en es it fr

(-)-Carnitine Brand names, (-)-Carnitine Analogs

(-)-Carnitine Brand Names Mixture

  • No information avaliable

(-)-Carnitine Chemical_Formula

C16H16ClN3O4

(-)-Carnitine RX_link

http://www.rxlist.com/cgi/generic/loracarb.htm

(-)-Carnitine fda sheet

(-)-Carnitine msds (material safety sheet)

(-)-Carnitine MSDS

(-)-Carnitine Synthesis Reference

No information avaliable

(-)-Carnitine Molecular Weight

349.769 g/mol

(-)-Carnitine Melting Point

No information avaliable

(-)-Carnitine H2O Solubility

No information avaliable

(-)-Carnitine State

Solid

(-)-Carnitine LogP

0.286

(-)-Carnitine Dosage Forms

No information avaliable

(-)-Carnitine Indication

Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

(-)-Carnitine Pharmacology

Loracarbef is considered a second generation cephalosporin antibiotic. The advantages of cephalosporin antibiotics include a broad range of activity, a safe record in children with almost no dose-related toxicity, and the lack of need to monitor levels. Adverse reactions are rare and consist primarily of hypersensitivity reactions with urticaria, nonspecific rash, and pruritus. Loracarbef can be used to treat a large number of bacterial infections caused by gram-negative and gram-positive bacteria, including upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

(-)-Carnitine Absorption

Well absorbed with approximately 90% absorbed from the gastrointestinal tract after oral ingestion.

(-)-Carnitine side effects and Toxicity

Adverse effects include diarrhea, nausea, stomach upset, vomiting, headache, dizziness, rash, bone marrow depression.

(-)-Carnitine Patient Information

http://www.drugs.com/MTM/lomefloxacin.html

(-)-Carnitine Organisms Affected

Many kinds of gram-negative and gram-positive eubacteria